Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inmed Pharmaceuticals Inc (NQ: INM )

2.850 +0.170 (+6.34%)
Streaming Delayed Price Updated: 1:00 PM EST, Nov 25, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 189,350
Open 2.600
Bid (Size) 2.870 (3)
Ask (Size) 2.880 (1)
Prev. Close 2.680
Today's Range 2.600 - 2.900
52wk Range 2.400 - 54.50
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
InMed Pharmaceuticals Secures $6M Via Private Placement
InMed Pharmaceuticals Inc. (NASDAQ: INM) closed its private placement with two healthcare-focused institutional investors for the issuance and sale of 1.8 million of its common shares 
Via Benzinga
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Close on $6M Private Placement Funding
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property

Performance

YTD
-91.62%
-91.62%
1 Month
-11.21%
-11.21%
3 Month
-52.50%
-52.50%
6 Month
-85.19%
-85.19%
1 Year
-93.21%
-93.21%

More News

Read More
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Close on $6M Private Placement Funding
Via CannabisNewsWire
Topics Intellectual Property
Exposures Intellectual Property
InMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to Market
From InMed Pharmaceuticals Inc.
Via Globe NewsWire
Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday
Via Benzinga
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Anticipated $6M Private Placement Funding
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Anticipated $6M Private Placement Funding
Via CannabisNewsWire
Topics Intellectual Property
Exposures Intellectual Property
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
From InMed Pharmaceuticals Inc.
Via Globe NewsWire
TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Accounting VP, Controller
Via Investor Brand Network
InMed Provides Update on Management Changes
From InMed Pharmaceuticals Inc.
Via Globe NewsWire
Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday
Via Benzinga
InMed Pharmaceuticals (NASDAQ: INM) Says Research Grant to Test Cannabinoid Analogs as a Potential Treatment for Alzheimer’s, Parkinson’s and Huntington’s Disease
Via Spotlight Growth
S&P 500 Down 0.8%; Lowe's Earnings Top Expectations
Via Benzinga
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Gains Alliance Grant Funding, Launches New Program with UBC Professor
Via Investor Brand Network
Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Dow Edges Higher; Crude Oil Drops Sharply
Via Benzinga
Nasdaq Drops Over 100 Points; US Retail Sales Rise 1.3%
Via Benzinga
InMed Pharmaceuticals Advances Neurodegenerative Disease Program with Natural Sciences and Engineering Research Council of Canada ("NSERC") Alliance Grant Funding
From InMed Pharmaceuticals Inc.
Via Globe NewsWire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q1 2023 Financial Report, Corporate Update
Via Investor Brand Network
Tyson Foods, AECOM And 3 Stocks To Watch Heading Into Monday
Via Benzinga
InMed Pharmaceuticals Reports First Quarter Fiscal 2023 Financial Results and Provides Business Update
From InMed Pharmaceuticals Inc.
Via Globe NewsWire
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at ‘Exploring the Neuroprotective Qualities of Rare Cannabinoids’ Webinar Event
Via Investor Brand Network
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.